“
TL;DR
The study found a high prevalence of Long-COVID GI manifestations in these populations, with anorexia, loss of taste, and abdominal pain being the most common.
World Journal of Gastroenterology · 9 authors, 9 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The study found a high prevalence of Long-COVID GI manifestations in these populations, with anorexia, loss of taste, and abdominal pain being the most common.
Among the 577 participants interviewed, Long-COVID was identified in 56% of hemodialysis, 62% of peritoneal dialysis, and 37% of kidney transplant patients. The most common GI manifestations were anorexia (90.9%), loss of taste (64.4%), and abdominal pain (62.5%). The study found that peritoneal dialysis patients had a higher prevalence of Long-COVID than hemodialysis or transplant patients. Six cases of mesenteric panniculitis were noted in the transplant group.